Cell, Gene

Cell and Gene Therapy in Parkinson's Disease Clinical Trial Pipeline Analysis Demonstrates 18+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

07.08.2025 - 18:05:41 | prnewswire.co.uk

DelveInsight Business Research, LLP United Kingdom United States of America

 
+14699457679
www.delveinsight.com 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/cell-and-gene-therapy-in-parkinsons-disease-clinical-trial-pipeline-analysis-demonstrates-18-key-companies-at-the-horizon-expected-to-transform-the-treatment-paradigm-assesses-delveinsight-302270984.html

en | boerse | 67967612 |